ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,698Medicare Part D Prescriptions Filled, Including Refills

Rank: 198 out of 676

$773K Total Retail Price of All Prescriptions

Rank: 105 out of 676

399 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 399 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

33% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

5% of this provider’s 5,686 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 800 288 S3 1 1
FUROSEMIDE 314 202 2 4
OMEPRAZOLE 234 143 3 2
NEXIUM 233 117 4 23
ZOLPIDEM TARTRATE 232 108 5 21
POTASSIUM CHLORIDE 196 154 6 9
LYRICA 190 69 7 57
LEVOTHYROXINE SODIUM 183 120 8 7
DIOVAN HCT 181 61 9 41
METOPROLOL TARTRATE 180 106 10 22
AMLODIPINE BESYLATE 176 88 11 3
SIMVASTATIN 173 105 12 6
GABAPENTIN 165 61 13 10
TRAMADOL HCL 142 73 14 19
WARFARIN SODIUM 137 102 15 18
TIZANIDINE HCL 135 47 16 68
SERTRALINE HCL 135 55 16 26
LISINOPRIL 127 88 18 5
CARISOPRODOL 123 28 R 19 60
DIOVAN 123 88 19 37
CITALOPRAM HBR 121 78 21 17
HYDROCHLOROTHIAZIDE 114 82 22 12
VENLAFAXINE HCL ER 104 86 23 98
CARVEDILOL 102 77 24 15
AMITRIPTYLINE HCL 101 52 R 25 46
CLOPIDOGREL 99 88 26 28
PANTOPRAZOLE SODIUM 97 51 27 42
OXYCONTIN 96 11 S2 28 235
CYMBALTA 94 53 29 47
DONEPEZIL HCL 92 92 30 24
CIPROFLOXACIN HCL 91 60 31 45
DIGOXIN 91 71 31 52
SUBOXONE 90 14 33 173
MELOXICAM 89 49 34 13
NAMENDA 83 83 35 35
POLYETHYLENE GLYCOL 3350 83 63 35 56
OXYCODONE HCL-ACETAMINOPHEN 82 14 S2 37 139
OXYCODONE HCL 80 14 S2 38 165
PRAVASTATIN SODIUM 78 50 39 11
NAPROXEN 77 39 40 71
METFORMIN HCL 75 57 41 8
CRESTOR 74 48 42 29
CLONIDINE HCL 74 31 42 32
FENTANYL 73 22 S2 44 93
METOPROLOL SUCCINATE 73 31 44 14
CYCLOBENZAPRINE HCL 70 36 R 46 50
CELEBREX 64 27 47 108
RANITIDINE HCL 59 39 48 27
PAROXETINE HCL 58 30 49 65
PLAVIX 54 43 50 40
FLUOXETINE HCL 54 22 50 70
EXFORGE 52 28 52 132
SYNTHROID 52 52 52 48
AZITHROMYCIN 52 32 52 39
JANUMET 51 41 55 167
MEGESTROL ACETATE 50 45 R 56 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.